| |
| |
|
| Insider
Information: |
Guggenhime Andrew |
| Relationship: |
|
| City: |
San Jose |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
108,934 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$32,740 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
108,934 |
|
|
| Total
Value |
$32,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
SVP & Chief Financial ... |
2008-12-18 |
13,255 |
2006-04-03 |
0 |
Premium* |
|
|
Vaxcyte, Inc. |
PCVX |
|
2024-05-20 |
95,679 |
2021-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PDLI |
PDL Biopharma Inc |
SVP & Chief Financial Officer |
• – – |
2006-04-03 |
4 |
A |
$32.49 |
$243,675 |
D/D |
7,500 |
7,500 |
|
- |
|
| PDLI |
PDL Biopharma Inc |
SVP & Chief Financial Officer |
• – – |
2008-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
16,830 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
40,625 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
83,729 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
99,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2021-12-23 |
4 |
AS |
$24.00 |
$74,400 |
D/D |
(3,100) |
3,125 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-03-01 |
4 |
AS |
$24.00 |
$148,800 |
D/D |
(6,200) |
3,125 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-03-18 |
4 |
AS |
$26.13 |
$80,993 |
D/D |
(3,100) |
40,625 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-04-18 |
4 |
AS |
$24.05 |
$74,542 |
D/D |
(3,100) |
40,625 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-05-18 |
4 |
AS |
$24.26 |
$75,763 |
D/D |
(3,100) |
42,187 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-07-08 |
4 |
AS |
$24.00 |
$74,400 |
D/D |
(3,100) |
42,187 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-07-18 |
4 |
AS |
$24.53 |
$76,047 |
D/D |
(3,100) |
42,187 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-08-18 |
4 |
AS |
$25.13 |
$78,320 |
D/D |
(3,100) |
42,187 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-08-25 |
4 |
AS |
$28.00 |
$477,456 |
D/D |
(17,052) |
42,187 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-08-26 |
4 |
AS |
$28.00 |
$36,260 |
D/D |
(1,295) |
42,187 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-08-29 |
4 |
AS |
$28.00 |
$494,284 |
D/D |
(17,653) |
42,187 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-09-19 |
4 |
AS |
$26.02 |
$80,898 |
D/D |
(3,100) |
37,538 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-10-18 |
4 |
AS |
$45.89 |
$367,300 |
D/D |
(8,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-11-20 |
4 |
AS |
$51.12 |
$409,063 |
D/D |
(8,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-12-14 |
4 |
AS |
$60.22 |
$843,080 |
D/D |
(14,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-12-18 |
4 |
AS |
$60.17 |
$481,417 |
D/D |
(8,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-01-18 |
4 |
AS |
$60.28 |
$485,879 |
D/D |
(8,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-02-20 |
4 |
AS |
$74.08 |
$596,232 |
D/D |
(8,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-03-18 |
4 |
AS |
$69.00 |
$552,144 |
D/D |
(8,000) |
95,679 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-04-18 |
4 |
AS |
$61.24 |
$490,199 |
D/D |
(8,000) |
95,679 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
